In conclusion, these data suggest that targeting CXCL1-CXCR2 and NETs formation could effectively prevent lung metastasis in SPP1-positive HCC patients, but early intervention is crucial for successful treatment (Fig. 7). This evidence concerns the gene CXCL1 and hepatocellular carcinoma.